2-Methoxy-1,4-Naphthoquinone (MNQ) suppresses the invasion and migration of a human metastatic breast cancer cell line (MDA-MB-231)

Toxicology in Vitro

Volumn 28, Issue 3, 2014, Pages 335-339

  Liew, Kitson ^a   Yong, Phelim Voon Chen ^a   Lim, Yang Mooi ^b   Navaratnam, Visweswaran ^a   Ho, Anthony Siong Hock ^a  

^a TAYLOR S UNIVERSITY   (Malaysia)

^b UNIVERSITI TUNKU ABDUL RAHMAN   (Malaysia)

Author keywords

2 Methoxy 1,4 Naphthoquinone; Invasion; Matrix metalloproteinases; MDA MB 231 cells; Metastasis; Migration

Indexed keywords

1,4 NAPHTHOQUINONE; 2 METHOXY 1,4 NAPHTHOQUINONE; GELATIN; GELATINASE B; MATRIGEL; UNCLASSIFIED DRUG;

ARTICLE; BREAST METASTASIS; CANCER CELL CULTURE; CANCER INHIBITION; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFECT; DRUG STRUCTURE; HUMAN; HUMAN CELL; IN VITRO STUDY; PROTEIN DEGRADATION; TUMOR INVASION; WOUND HEALING; ZYMOGRAPHY;

2-METHOXY-1,4-NAPHTHOQUINONE; INVASION; MATRIX METALLOPROTEINASES; MDA-MB-231 CELLS; METASTASIS; MIGRATION;

ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL MOVEMENT; COLLAGEN; DOSE-RESPONSE RELATIONSHIP, DRUG; DOWN-REGULATION; DRUG COMBINATIONS; FEMALE; HUMANS; LAMININ; MATRIX METALLOPROTEINASE 9; NAPHTHOQUINONES; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; PROTEOGLYCANS;

EID: 84891675405     PISSN: 08872333     EISSN: 18793177     Source Type: Journal    
DOI: 10.1016/j.tiv.2013.11.008     Document Type: Article

References (26)

1. Albini A., Agostini F., Giunciuglio D., Paglieri I., Balansky R., De Flora S. Inhibition of invasion, gelatinase activity, tumor take and metastasis of malignant cells by N-acetylcysteine. Int. J. Cancer 1995, 61:121-129.
2. Bjorklund M., Koivunen E. Gelatinase-mediated migration and invasion of cancer cells. Biochim. Biophys. Acta 2005, 1755:37-69.
3. Ding Z.S., Jiang F.S., Chen N.P., Lv G.Y., Zhu C.G. Isolation and identification of an anti-tumor component from leaves of Impatiens balsamina. Molecule 2008, 13:220-229.
4. Geiger T.R., Peeper D.S. Metastasis mechanism. Biochim. Biophys. Acta 2009, 1796:293-298.
5. Hua H., Li M., Luo T., Yin Y., Jiang Y. Matrix metalloproteinases in tumorigenesis: an evolving paradigm. Cell. Mol. Life Sci. 2011, 68:3853-3868.
6. Jiang Y., Liu Z. Natural products as anti-invasive and anti-metastatic agents. Curr. Med. Chem. 2011, 18:808-829.
7. Kessenbrock K., Plaks V., Werb Z. Matrix metalloproteinases: regulators of the tumor microenvironment. Cell 2010, 141:52-67.
8. Ling H., Zhang Y., Ng K., Chew E. Pachymic acid impairs breast cancer cell invasion by suppressing nuclear factor-κB-dependent matrix metalloproteinase-9 expression. Breast Cancer Res. Treat. 2011, 126:609-620.
9. Lynch C.C., Matrisian L.M. Matrix metalloproteinases in tumor - host cell communication. Differentiation 2002, 70:561-573.
10. Min R., Zun Z., Min Y., Wenhu D., Wenjun Y., Chenping Y. Shikonin inhibits tumor invasion via downregulation of NF-κB-mediated MMP-9 expression in human ACC-M cells. Oral Dis. 2011, 17:362-369.
11. Mori N., Toume K., Arai M.A., Koyano T., Kowithayakorn T., Ishibashi M. 2-methoxy-1,4-naphthoquinone isolated from Impatiens balsamina in a screening program for activity to inhibit Wnt signaling. J. Nat. Med. 2011, 65:234-236.
12. Nabeshima K., Inoue T., Shimao Y., Sameshima T. Matrix metalloproteinases in tumor invasion: role for cell migration. Pathol. Int. 2002, 52:255-264.
13. Rolli M., Fransvea E., Pilch J., Saven A., Felding-Habermann B. Activated integrin alphavbeta3 cooperates with metalloproteinase MMP-9 in regulating migration of metastatic breast cancer cells. Proc. Natl. Acad. Sci. USA 2003, 100:9482-9487.
14. Sethi N., Kang Y. Unravelling the complexity of metastasis - molecular understanding and targeted therapies. Nat. Rev. Cancer 2011, 11:735-748.
15. Shieh J.M., Chiang T.A., Chang W.T., Chao C.H., Lee Y.C., Huang G.Y., Shih Y.X., Shih Y.W. Plumbagin inhibits TPA-induced MMP-2 and u-PA expressions by reducing binding activities of NF-kB and AP-1 via ERK signaling pathway in A549 human lung cancer cells. Mol. Cell. Biochem. 2010, 335:181-193.
16. Shih Y.W., Lee Y.C., Wu P.F., Lee Y.B., Chiang T.A. Plumbagin inhibits invasion and migration of liver cancer HepG2 cells by decreasing productions of matrix metalloproteinase-2 and urokinase-plasminogen activator. Hepatol. Res. 2009, 39:998-1009.
17. Shu L., Cheung K., Khor T.O., Chen C., Kong A. Phytochemicals: cancer chemoprevention and suppression of tumor onset and metastasis. Cancer Metastasis Rev. 2010, 29:483-502.
18. Tan, S.Y., 2011. Differential protein expression in human chronic myelogenous leukaemia cell line (K562) following exposure to 2-Methoxy-1,4-Naphthoquinone isolated from Impatiens Balsamina Linn. MS Thesis Dissertation, Department of Science, Faculty of Engineering and Science, Universiti Tunku Abdul Rahman, Kuala Lumpur, Malaysia.
19. Teng, O., 2010. Isolation and characterisation of a cytotoxic naphthoquinone from Impatiens balsamina. MS Thesis Dissertation, Department of Science, Faculty of Engineering and Science, Universiti Tunku Abdul Rahman, Kuala Lumpur, Malaysia.
20. Toth M., Sohail A., Fridman R. Assessment of gelatinases (MMP-2 and MMP-9) by gelatin zymography. Metastasis Research Protocols, Methods in Molecular Biology 2012, vol. 878:121-135. Humana Press Inc., Totowa, New Jersey.
21. Valastyan S., Weinberg R.A. Tumor metastasis: molecular insights and evolving paradigms. Cell 2011, 147:275-292.
22. Wang Y.C., Lin Y.H. Anti-gastric adenocarcinoma activity of 2-Methoxy-1,4-naphthoquinone, an anti-Helicobacter pylori compound from Impatiens balsamina L. Fitoterapia 2012, 83:1336-1344.
23. Weber G.F. Why does cancer therapy lack effective anti-metastasis drugs?. Cancer Lett. 2013, 328:207-211.
24. Weng C., Yen G. Chemopreventive effects of dietary phytochemicals against cancer invasion and metastasis: Phenolic acids, monophenol, polyphenol, and their derivatives. Cancer Treat. Rev. 2012, 38:76-87.
25. Yan C., Boyd D.D. Regulation of matrix metalloproteinase gene expression. J. Cell Physiol. 2007, 211:19-26.
26. Zhang S., Li Z., Wu X., Huang Q., Shen H.M., Ong C.N. Methyl-3-indolylacetate inhibits cancer cell invasion by targeting the MEK1/2-ERK1/2 signaling pathway. Mol. Cancer Ther. 2006, 5:3285-3293.